Health In Technology Inc

HIT

Latest QuantConomy context for HIT: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class

stock

Primary venue

NASDAQ

Recent signals

SEC filings

Asset profile

QuantConomy has a structured record for HIT. More descriptive asset metadata will appear here when the platform record includes it.

Latest signal rows

Recent signals for HIT

Scored rows are pulled from the same signal API used by the digests.

Signal	Direction	Score	Observed	Reason
fundamental eps change	very bearish	64	May 14, 12:00 AM	HIT (Q1 2026, diluted eps): EPS turned negative ($0.02 → $-0.03). [sequential period basis, very bearish signal]
fundamental net income change	very bearish	68	May 14, 12:00 AM	HIT (Q1 2026, net income): swung to a loss ($1.28M → -$1.59M). [sequential period basis, very bearish signal]
fundamental revenue change	very bearish	76	May 14, 12:00 AM	HIT (Q1 2026, revenue): declined 78.6% ($6.86M → $1.47M). [sequential period basis, very bearish signal]

FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.

Market	Exchange	Source	Asset record
HIT	NASDAQ	alphavantage	Health In Tech Inc - Class A
HIT	NASDAQ	alpaca	Health In Tech, Inc. Class A Common Stock
HIT	NASDAQ	fmp	Health In Tech, Inc.

Buys, last 90d

Sells, last 90d

Rows

Date	Insider	Role	Type	Shares	Price	Value	Filing
Jul 8, 2026	Howard William D.	Insider	grant	18,867	$1.06	$19,999	4 on EDGAR
Jul 8, 2026	Shrestha Sanjay K	Insider	grant	18,867	$1.06	$19,999	4 on EDGAR
Jul 8, 2026	Hayes Timothy	Insider	grant	18,867	$1.06	$19,999	4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.